Medicaments intended for combined use in the improvement of lymp

Details Medicaments intended for combined use in the improvement of lymp Medicaments intended for combined use in the improvement of lymp

1990-05-25

1991-12-17

Friedman, Stanley J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

514474, A61K 3134, A61K 3150, A61K 31495

Patent

active

050735551

ABSTRACT:
A new composition, useful as a medicament, contains ascorbate, preferably as metallic salt(s), in combination with a dopamine agonist such as bromocriptine, with the ratio by weight of ascorbate to bromocriptine being 400:1 or greater. This combination, believed to act through stimulation of pituitary production of somatotropin, has a significant ability to stimulate enhanced lymphocyte function to result in method to reduce cholesterol levels in humans.

Affiliated with

Also associated with

Rating

Medicaments intended for combined use in the improvement of lymp does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Medicaments intended for combined use in the improvement of lymp, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medicaments intended for combined use in the improvement of lymp will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-835815